Cargando…
Characterization of blood-derived exosomal hTERT mRNA as a biomarker for colon cancer and Lynch syndrome
BACKGROUND: Human telomerase reverse transcriptase (hTERT)- mRNA was shown to be elevated in exosomes derived from the sera of a variety of hematological and solid cancer patients. We aimed to evaluate its role as a diagnostic marker in patients with newly diagnosed colon cancer and in hereditary sy...
Autores principales: | Laish, Ido, Levi, Zohar, Mahajna, Hussein, Albshesh, Ahmad, Horesh, Nir, Katz, Efraim, Feldman, Dan, Shinar, Nadav, Picard, Orit, Yavzori, Miri, Fudim, Ella, Raanani, Pia, Berger, Tamar, Goldvaser, Hadar, Beery, Einat, Uziel, Orit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530579/ https://www.ncbi.nlm.nih.gov/pubmed/36203446 http://dx.doi.org/10.3389/fonc.2022.962473 |
Ejemplares similares
-
Tumor cells derived exosomes contain hTERT mRNA and transform nonmalignant fibroblasts into telomerase positive cells
por: Gutkin, Anna, et al.
Publicado: (2016) -
Characterisation of blood-derived exosomal hTERT mRNA secretion in cancer patients: a potential pan-cancer marker
por: Goldvaser, Hadar, et al.
Publicado: (2017) -
Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy
por: Rotem, Ofer, et al.
Publicado: (2023) -
The Effects of Proteasome Inhibitors on Telomerase Activity and Regulation in Multiple Myeloma Cells
por: Shalem-Cohavi, Naama, et al.
Publicado: (2019) -
Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?
por: Levartovsky, Asaf, et al.
Publicado: (2023)